Upregulation of Bradykinin B2 Receptor Expression by Neurotrophic Factors and Nerve Injury in Mouse Sensory Neurons

Bradykinin B2 receptor mRNA was detected at low levels, both by RT-PCR and by in situ hybridization, in freshly isolated dorsal root ganglia (DRG) and in ganglia cultured in the absence of neurotrophic factors, but was strongly upregulated by culture in the presence of nerve growth factor (NGF). The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular and cellular neuroscience 2002-02, Vol.19 (2), p.186-200
Hauptverfasser: Lee, Yih-Jing, Zachrisson, Olof, Tonge, David A., McNaughton, Peter A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 200
container_issue 2
container_start_page 186
container_title Molecular and cellular neuroscience
container_volume 19
creator Lee, Yih-Jing
Zachrisson, Olof
Tonge, David A.
McNaughton, Peter A.
description Bradykinin B2 receptor mRNA was detected at low levels, both by RT-PCR and by in situ hybridization, in freshly isolated dorsal root ganglia (DRG) and in ganglia cultured in the absence of neurotrophic factors, but was strongly upregulated by culture in the presence of nerve growth factor (NGF). The effect of NGF is mediated via TrkA receptors. The related neurotrophins, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4, were ineffective in upregulating B2 mRNA, but a small upregulation was seen with the unrelated neurotrophin glial cell line-derived neurotrophic factor (GDNF). Surface membrane B2 receptor expression, detected by immunofluorescence using a B2-specific antibody, was low in outgrowing axons cultured in the absence of neurotrophic factors, but was elevated by addition of NGF or GDNF. Conditioned media prepared by incubating injured nerve, skin, or muscle had a similar effect to NGF in upregulating B2 mRNA and protein expression, and the activity was largely removed by neutralization of NGF in the conditioned medium with an anti-NGF antibody. After nerve crush injury in vivo an enhancement in B2 mRNA expression was seen, peaking after 7 days and returning to precrush levels after 14 days. In all conditions tested, the proportion of neurons expressing B2 mRNA remained the same at around 23% of small neurons, suggesting that upregulation only occurs in the B2-positive neurons. These experiments show that NGF, and to a lesser extent GDNF, upregulates the expression of bradykinin B2 mRNA and B2 receptor protein in the surface membrane of DRG neurons and that NGF is an important factor responsible for upregulating bradykinin B2 receptor expression after nerve crush injury in vivo.
doi_str_mv 10.1006/mcne.2001.1073
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71460964</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1044743101910735</els_id><sourcerecordid>71460964</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-be5ee64ba7130ddb0f52fb361d6d4cfe28d5db9975aeeaff6897f86a36e8431c3</originalsourceid><addsrcrecordid>eNqFkc9PHCEUx0lTU3-0V48Np95mhYEB5liNWhPbJlXPhIGHxe7CFGaM-9-XyW7iqfHEI3zeN4_3QeiUkhUlRJxtbIRVSwitV8neoSNK-q7pWSvfLzXnjeSMHqLjUp4IIV3bsw_okFIlSCvbI1QexgyP89pMIUWcPD7Pxm3_hBgiPm_xL7AwTinjy5fKlbJAwxb_gDmnKafxd7D4ythKFGyiqw_5GfBNfJrzFteI72kugO8glpT3bbF8RAferAt82p8n6OHq8v7iW3P78_rm4uttYzmTUzNAByD4YCRlxLmB-K71AxPUCceth1a5zg19LzsDYLwXqpdeCcMEqPpny07Ql13umNPfGcqkN6FYWK9NhDqXlpQL0gv-JkgVE1yproKrHWhzKiWD12MOG5O3mhK9-NCLD7340IuP2vB5nzwPG3Cv-F5ABdQOgLqI5wBZFxsgWnAhg520S-F_2f8APp-b3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18364885</pqid></control><display><type>article</type><title>Upregulation of Bradykinin B2 Receptor Expression by Neurotrophic Factors and Nerve Injury in Mouse Sensory Neurons</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lee, Yih-Jing ; Zachrisson, Olof ; Tonge, David A. ; McNaughton, Peter A.</creator><creatorcontrib>Lee, Yih-Jing ; Zachrisson, Olof ; Tonge, David A. ; McNaughton, Peter A.</creatorcontrib><description>Bradykinin B2 receptor mRNA was detected at low levels, both by RT-PCR and by in situ hybridization, in freshly isolated dorsal root ganglia (DRG) and in ganglia cultured in the absence of neurotrophic factors, but was strongly upregulated by culture in the presence of nerve growth factor (NGF). The effect of NGF is mediated via TrkA receptors. The related neurotrophins, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4, were ineffective in upregulating B2 mRNA, but a small upregulation was seen with the unrelated neurotrophin glial cell line-derived neurotrophic factor (GDNF). Surface membrane B2 receptor expression, detected by immunofluorescence using a B2-specific antibody, was low in outgrowing axons cultured in the absence of neurotrophic factors, but was elevated by addition of NGF or GDNF. Conditioned media prepared by incubating injured nerve, skin, or muscle had a similar effect to NGF in upregulating B2 mRNA and protein expression, and the activity was largely removed by neutralization of NGF in the conditioned medium with an anti-NGF antibody. After nerve crush injury in vivo an enhancement in B2 mRNA expression was seen, peaking after 7 days and returning to precrush levels after 14 days. In all conditions tested, the proportion of neurons expressing B2 mRNA remained the same at around 23% of small neurons, suggesting that upregulation only occurs in the B2-positive neurons. These experiments show that NGF, and to a lesser extent GDNF, upregulates the expression of bradykinin B2 mRNA and B2 receptor protein in the surface membrane of DRG neurons and that NGF is an important factor responsible for upregulating bradykinin B2 receptor expression after nerve crush injury in vivo.</description><identifier>ISSN: 1044-7431</identifier><identifier>EISSN: 1095-9327</identifier><identifier>DOI: 10.1006/mcne.2001.1073</identifier><identifier>PMID: 11860272</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Bradykinin - metabolism ; Cells, Cultured ; Culture Media, Conditioned - pharmacology ; Female ; Ganglia, Spinal - drug effects ; Ganglia, Spinal - injuries ; Ganglia, Spinal - metabolism ; Glial Cell Line-Derived Neurotrophic Factor ; Growth Cones - drug effects ; Growth Cones - metabolism ; Hyperalgesia - metabolism ; Hyperalgesia - physiopathology ; Immunohistochemistry ; In Situ Hybridization ; Mice ; Mice, Inbred Strains ; Nerve Crush ; Nerve Growth Factor - antagonists &amp; inhibitors ; Nerve Growth Factor - metabolism ; Nerve Growth Factors - metabolism ; Nerve Growth Factors - pharmacology ; Nerve Regeneration - drug effects ; Nerve Regeneration - genetics ; Nerve Tissue Proteins - metabolism ; Nerve Tissue Proteins - pharmacology ; Neurons, Afferent - drug effects ; Neurons, Afferent - metabolism ; Receptor, Bradykinin B2 ; Receptors, Bradykinin - drug effects ; Receptors, Bradykinin - genetics ; Receptors, Bradykinin - metabolism ; Receptors, Cell Surface - drug effects ; Receptors, Cell Surface - metabolism ; RNA, Messenger - drug effects ; RNA, Messenger - metabolism ; Up-Regulation - drug effects ; Up-Regulation - genetics</subject><ispartof>Molecular and cellular neuroscience, 2002-02, Vol.19 (2), p.186-200</ispartof><rights>2002 Elsevier Science (USA)</rights><rights>(C)2002 Elsevier Science (USA).</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-be5ee64ba7130ddb0f52fb361d6d4cfe28d5db9975aeeaff6897f86a36e8431c3</citedby><cites>FETCH-LOGICAL-c437t-be5ee64ba7130ddb0f52fb361d6d4cfe28d5db9975aeeaff6897f86a36e8431c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1044743101910735$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11860272$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Yih-Jing</creatorcontrib><creatorcontrib>Zachrisson, Olof</creatorcontrib><creatorcontrib>Tonge, David A.</creatorcontrib><creatorcontrib>McNaughton, Peter A.</creatorcontrib><title>Upregulation of Bradykinin B2 Receptor Expression by Neurotrophic Factors and Nerve Injury in Mouse Sensory Neurons</title><title>Molecular and cellular neuroscience</title><addtitle>Mol Cell Neurosci</addtitle><description>Bradykinin B2 receptor mRNA was detected at low levels, both by RT-PCR and by in situ hybridization, in freshly isolated dorsal root ganglia (DRG) and in ganglia cultured in the absence of neurotrophic factors, but was strongly upregulated by culture in the presence of nerve growth factor (NGF). The effect of NGF is mediated via TrkA receptors. The related neurotrophins, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4, were ineffective in upregulating B2 mRNA, but a small upregulation was seen with the unrelated neurotrophin glial cell line-derived neurotrophic factor (GDNF). Surface membrane B2 receptor expression, detected by immunofluorescence using a B2-specific antibody, was low in outgrowing axons cultured in the absence of neurotrophic factors, but was elevated by addition of NGF or GDNF. Conditioned media prepared by incubating injured nerve, skin, or muscle had a similar effect to NGF in upregulating B2 mRNA and protein expression, and the activity was largely removed by neutralization of NGF in the conditioned medium with an anti-NGF antibody. After nerve crush injury in vivo an enhancement in B2 mRNA expression was seen, peaking after 7 days and returning to precrush levels after 14 days. In all conditions tested, the proportion of neurons expressing B2 mRNA remained the same at around 23% of small neurons, suggesting that upregulation only occurs in the B2-positive neurons. These experiments show that NGF, and to a lesser extent GDNF, upregulates the expression of bradykinin B2 mRNA and B2 receptor protein in the surface membrane of DRG neurons and that NGF is an important factor responsible for upregulating bradykinin B2 receptor expression after nerve crush injury in vivo.</description><subject>Animals</subject><subject>Bradykinin - metabolism</subject><subject>Cells, Cultured</subject><subject>Culture Media, Conditioned - pharmacology</subject><subject>Female</subject><subject>Ganglia, Spinal - drug effects</subject><subject>Ganglia, Spinal - injuries</subject><subject>Ganglia, Spinal - metabolism</subject><subject>Glial Cell Line-Derived Neurotrophic Factor</subject><subject>Growth Cones - drug effects</subject><subject>Growth Cones - metabolism</subject><subject>Hyperalgesia - metabolism</subject><subject>Hyperalgesia - physiopathology</subject><subject>Immunohistochemistry</subject><subject>In Situ Hybridization</subject><subject>Mice</subject><subject>Mice, Inbred Strains</subject><subject>Nerve Crush</subject><subject>Nerve Growth Factor - antagonists &amp; inhibitors</subject><subject>Nerve Growth Factor - metabolism</subject><subject>Nerve Growth Factors - metabolism</subject><subject>Nerve Growth Factors - pharmacology</subject><subject>Nerve Regeneration - drug effects</subject><subject>Nerve Regeneration - genetics</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Nerve Tissue Proteins - pharmacology</subject><subject>Neurons, Afferent - drug effects</subject><subject>Neurons, Afferent - metabolism</subject><subject>Receptor, Bradykinin B2</subject><subject>Receptors, Bradykinin - drug effects</subject><subject>Receptors, Bradykinin - genetics</subject><subject>Receptors, Bradykinin - metabolism</subject><subject>Receptors, Cell Surface - drug effects</subject><subject>Receptors, Cell Surface - metabolism</subject><subject>RNA, Messenger - drug effects</subject><subject>RNA, Messenger - metabolism</subject><subject>Up-Regulation - drug effects</subject><subject>Up-Regulation - genetics</subject><issn>1044-7431</issn><issn>1095-9327</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9PHCEUx0lTU3-0V48Np95mhYEB5liNWhPbJlXPhIGHxe7CFGaM-9-XyW7iqfHEI3zeN4_3QeiUkhUlRJxtbIRVSwitV8neoSNK-q7pWSvfLzXnjeSMHqLjUp4IIV3bsw_okFIlSCvbI1QexgyP89pMIUWcPD7Pxm3_hBgiPm_xL7AwTinjy5fKlbJAwxb_gDmnKafxd7D4ythKFGyiqw_5GfBNfJrzFteI72kugO8glpT3bbF8RAferAt82p8n6OHq8v7iW3P78_rm4uttYzmTUzNAByD4YCRlxLmB-K71AxPUCceth1a5zg19LzsDYLwXqpdeCcMEqPpny07Ql13umNPfGcqkN6FYWK9NhDqXlpQL0gv-JkgVE1yproKrHWhzKiWD12MOG5O3mhK9-NCLD7340IuP2vB5nzwPG3Cv-F5ABdQOgLqI5wBZFxsgWnAhg520S-F_2f8APp-b3Q</recordid><startdate>20020201</startdate><enddate>20020201</enddate><creator>Lee, Yih-Jing</creator><creator>Zachrisson, Olof</creator><creator>Tonge, David A.</creator><creator>McNaughton, Peter A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20020201</creationdate><title>Upregulation of Bradykinin B2 Receptor Expression by Neurotrophic Factors and Nerve Injury in Mouse Sensory Neurons</title><author>Lee, Yih-Jing ; Zachrisson, Olof ; Tonge, David A. ; McNaughton, Peter A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-be5ee64ba7130ddb0f52fb361d6d4cfe28d5db9975aeeaff6897f86a36e8431c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Bradykinin - metabolism</topic><topic>Cells, Cultured</topic><topic>Culture Media, Conditioned - pharmacology</topic><topic>Female</topic><topic>Ganglia, Spinal - drug effects</topic><topic>Ganglia, Spinal - injuries</topic><topic>Ganglia, Spinal - metabolism</topic><topic>Glial Cell Line-Derived Neurotrophic Factor</topic><topic>Growth Cones - drug effects</topic><topic>Growth Cones - metabolism</topic><topic>Hyperalgesia - metabolism</topic><topic>Hyperalgesia - physiopathology</topic><topic>Immunohistochemistry</topic><topic>In Situ Hybridization</topic><topic>Mice</topic><topic>Mice, Inbred Strains</topic><topic>Nerve Crush</topic><topic>Nerve Growth Factor - antagonists &amp; inhibitors</topic><topic>Nerve Growth Factor - metabolism</topic><topic>Nerve Growth Factors - metabolism</topic><topic>Nerve Growth Factors - pharmacology</topic><topic>Nerve Regeneration - drug effects</topic><topic>Nerve Regeneration - genetics</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Nerve Tissue Proteins - pharmacology</topic><topic>Neurons, Afferent - drug effects</topic><topic>Neurons, Afferent - metabolism</topic><topic>Receptor, Bradykinin B2</topic><topic>Receptors, Bradykinin - drug effects</topic><topic>Receptors, Bradykinin - genetics</topic><topic>Receptors, Bradykinin - metabolism</topic><topic>Receptors, Cell Surface - drug effects</topic><topic>Receptors, Cell Surface - metabolism</topic><topic>RNA, Messenger - drug effects</topic><topic>RNA, Messenger - metabolism</topic><topic>Up-Regulation - drug effects</topic><topic>Up-Regulation - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Yih-Jing</creatorcontrib><creatorcontrib>Zachrisson, Olof</creatorcontrib><creatorcontrib>Tonge, David A.</creatorcontrib><creatorcontrib>McNaughton, Peter A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Yih-Jing</au><au>Zachrisson, Olof</au><au>Tonge, David A.</au><au>McNaughton, Peter A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upregulation of Bradykinin B2 Receptor Expression by Neurotrophic Factors and Nerve Injury in Mouse Sensory Neurons</atitle><jtitle>Molecular and cellular neuroscience</jtitle><addtitle>Mol Cell Neurosci</addtitle><date>2002-02-01</date><risdate>2002</risdate><volume>19</volume><issue>2</issue><spage>186</spage><epage>200</epage><pages>186-200</pages><issn>1044-7431</issn><eissn>1095-9327</eissn><abstract>Bradykinin B2 receptor mRNA was detected at low levels, both by RT-PCR and by in situ hybridization, in freshly isolated dorsal root ganglia (DRG) and in ganglia cultured in the absence of neurotrophic factors, but was strongly upregulated by culture in the presence of nerve growth factor (NGF). The effect of NGF is mediated via TrkA receptors. The related neurotrophins, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4, were ineffective in upregulating B2 mRNA, but a small upregulation was seen with the unrelated neurotrophin glial cell line-derived neurotrophic factor (GDNF). Surface membrane B2 receptor expression, detected by immunofluorescence using a B2-specific antibody, was low in outgrowing axons cultured in the absence of neurotrophic factors, but was elevated by addition of NGF or GDNF. Conditioned media prepared by incubating injured nerve, skin, or muscle had a similar effect to NGF in upregulating B2 mRNA and protein expression, and the activity was largely removed by neutralization of NGF in the conditioned medium with an anti-NGF antibody. After nerve crush injury in vivo an enhancement in B2 mRNA expression was seen, peaking after 7 days and returning to precrush levels after 14 days. In all conditions tested, the proportion of neurons expressing B2 mRNA remained the same at around 23% of small neurons, suggesting that upregulation only occurs in the B2-positive neurons. These experiments show that NGF, and to a lesser extent GDNF, upregulates the expression of bradykinin B2 mRNA and B2 receptor protein in the surface membrane of DRG neurons and that NGF is an important factor responsible for upregulating bradykinin B2 receptor expression after nerve crush injury in vivo.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11860272</pmid><doi>10.1006/mcne.2001.1073</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1044-7431
ispartof Molecular and cellular neuroscience, 2002-02, Vol.19 (2), p.186-200
issn 1044-7431
1095-9327
language eng
recordid cdi_proquest_miscellaneous_71460964
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Bradykinin - metabolism
Cells, Cultured
Culture Media, Conditioned - pharmacology
Female
Ganglia, Spinal - drug effects
Ganglia, Spinal - injuries
Ganglia, Spinal - metabolism
Glial Cell Line-Derived Neurotrophic Factor
Growth Cones - drug effects
Growth Cones - metabolism
Hyperalgesia - metabolism
Hyperalgesia - physiopathology
Immunohistochemistry
In Situ Hybridization
Mice
Mice, Inbred Strains
Nerve Crush
Nerve Growth Factor - antagonists & inhibitors
Nerve Growth Factor - metabolism
Nerve Growth Factors - metabolism
Nerve Growth Factors - pharmacology
Nerve Regeneration - drug effects
Nerve Regeneration - genetics
Nerve Tissue Proteins - metabolism
Nerve Tissue Proteins - pharmacology
Neurons, Afferent - drug effects
Neurons, Afferent - metabolism
Receptor, Bradykinin B2
Receptors, Bradykinin - drug effects
Receptors, Bradykinin - genetics
Receptors, Bradykinin - metabolism
Receptors, Cell Surface - drug effects
Receptors, Cell Surface - metabolism
RNA, Messenger - drug effects
RNA, Messenger - metabolism
Up-Regulation - drug effects
Up-Regulation - genetics
title Upregulation of Bradykinin B2 Receptor Expression by Neurotrophic Factors and Nerve Injury in Mouse Sensory Neurons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A29%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upregulation%20of%20Bradykinin%20B2%20Receptor%20Expression%20by%20Neurotrophic%20Factors%20and%20Nerve%20Injury%20in%20Mouse%20Sensory%20Neurons&rft.jtitle=Molecular%20and%20cellular%20neuroscience&rft.au=Lee,%20Yih-Jing&rft.date=2002-02-01&rft.volume=19&rft.issue=2&rft.spage=186&rft.epage=200&rft.pages=186-200&rft.issn=1044-7431&rft.eissn=1095-9327&rft_id=info:doi/10.1006/mcne.2001.1073&rft_dat=%3Cproquest_cross%3E71460964%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18364885&rft_id=info:pmid/11860272&rft_els_id=S1044743101910735&rfr_iscdi=true